

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.20906079 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.20906079 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.63874228 |
| 4 | proteasome assembly (GO:0043248) | 4.42477979 |
| 5 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.27677972 |
| 6 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 4.05996533 |
| 7 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.86080543 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78796243 |
| 9 | COPII vesicle coating (GO:0048208) | 3.78465146 |
| 10 | positive regulation of antigen processing and presentation (GO:0002579) | 3.71269319 |
| 11 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.70517260 |
| 12 | ribosome assembly (GO:0042255) | 3.60696933 |
| 13 | NADH metabolic process (GO:0006734) | 3.57313726 |
| 14 | valine metabolic process (GO:0006573) | 3.53245279 |
| 15 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.51030899 |
| 16 | respiratory burst (GO:0045730) | 3.49312854 |
| 17 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.36626234 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35027819 |
| 19 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.34741819 |
| 20 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.33828800 |
| 21 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.29163780 |
| 22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26907735 |
| 23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.24822469 |
| 24 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.21867485 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 3.21150985 |
| 26 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.17387082 |
| 27 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.17387082 |
| 28 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.17189066 |
| 29 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.17189066 |
| 30 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.17189066 |
| 31 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.16645663 |
| 32 | porphyrin-containing compound metabolic process (GO:0006778) | 3.16401820 |
| 33 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.10875904 |
| 34 | tetrapyrrole biosynthetic process (GO:0033014) | 3.10123124 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.09838059 |
| 36 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.08800808 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.07152184 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 3.07152184 |
| 39 | protein deneddylation (GO:0000338) | 3.07118980 |
| 40 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.04004619 |
| 41 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.04004619 |
| 42 | tricarboxylic acid cycle (GO:0006099) | 3.03707697 |
| 43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.00872859 |
| 44 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.99819704 |
| 45 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.99761571 |
| 46 | negative regulation of ligase activity (GO:0051352) | 2.99761571 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 2.98833200 |
| 48 | cysteine metabolic process (GO:0006534) | 2.98091727 |
| 49 | cytokinetic process (GO:0032506) | 2.97722659 |
| 50 | piRNA metabolic process (GO:0034587) | 2.96088728 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.95937316 |
| 52 | positive regulation of ligase activity (GO:0051351) | 2.95683294 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94654613 |
| 54 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.93270581 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.89575456 |
| 56 | kynurenine metabolic process (GO:0070189) | 2.87650961 |
| 57 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.87571411 |
| 58 | 7-methylguanosine mRNA capping (GO:0006370) | 2.84948625 |
| 59 | protein maturation by protein folding (GO:0022417) | 2.84898215 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84487352 |
| 61 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.81967878 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80237915 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80004493 |
| 64 | tryptophan metabolic process (GO:0006568) | 2.79555312 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 2.78976532 |
| 66 | ribonucleoprotein complex disassembly (GO:0032988) | 2.78310333 |
| 67 | signal peptide processing (GO:0006465) | 2.77949909 |
| 68 | low-density lipoprotein particle clearance (GO:0034383) | 2.77695672 |
| 69 | oxaloacetate metabolic process (GO:0006107) | 2.77316016 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 2.74830108 |
| 71 | aldehyde catabolic process (GO:0046185) | 2.74805999 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74772730 |
| 73 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.73815126 |
| 74 | 7-methylguanosine RNA capping (GO:0009452) | 2.73788523 |
| 75 | RNA capping (GO:0036260) | 2.73788523 |
| 76 | cellular response to zinc ion (GO:0071294) | 2.73683913 |
| 77 | tryptophan catabolic process (GO:0006569) | 2.69851938 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 2.69851938 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 2.69851938 |
| 80 | sulfur amino acid catabolic process (GO:0000098) | 2.69851548 |
| 81 | galactose catabolic process (GO:0019388) | 2.69695648 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.69601482 |
| 83 | L-phenylalanine catabolic process (GO:0006559) | 2.69601482 |
| 84 | respiratory electron transport chain (GO:0022904) | 2.67618093 |
| 85 | aromatic amino acid family catabolic process (GO:0009074) | 2.67296309 |
| 86 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67232238 |
| 87 | cullin deneddylation (GO:0010388) | 2.66247908 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.65836650 |
| 89 | tetrapyrrole metabolic process (GO:0033013) | 2.62683532 |
| 90 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.62364371 |
| 91 | electron transport chain (GO:0022900) | 2.61607000 |
| 92 | heart process (GO:0003015) | 2.60533538 |
| 93 | heart contraction (GO:0060047) | 2.60533538 |
| 94 | purine-containing compound salvage (GO:0043101) | 2.59390426 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.58813720 |
| 96 | L-phenylalanine metabolic process (GO:0006558) | 2.58813720 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.58376573 |
| 98 | complement activation, alternative pathway (GO:0006957) | 2.58300684 |
| 99 | regulation of cellular amine metabolic process (GO:0033238) | 2.55132768 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 2.53552126 |
| 101 | muscle filament sliding (GO:0030049) | 2.53415554 |
| 102 | actin-myosin filament sliding (GO:0033275) | 2.53415554 |
| 103 | response to hydroperoxide (GO:0033194) | 2.53334775 |
| 104 | lysine catabolic process (GO:0006554) | 2.52950332 |
| 105 | lysine metabolic process (GO:0006553) | 2.52950332 |
| 106 | sequestering of metal ion (GO:0051238) | 2.51876433 |
| 107 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.51399677 |
| 108 | amino-acid betaine transport (GO:0015838) | 2.50860685 |
| 109 | carnitine transport (GO:0015879) | 2.50860685 |
| 110 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.49220666 |
| 111 | ubiquinone biosynthetic process (GO:0006744) | 2.48645038 |
| 112 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.48627050 |
| 113 | urate metabolic process (GO:0046415) | 2.47765499 |
| 114 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.46546548 |
| 115 | apoptotic DNA fragmentation (GO:0006309) | 2.45679808 |
| 116 | purine nucleotide salvage (GO:0032261) | 2.45653540 |
| 117 | regulation of ligase activity (GO:0051340) | 2.45584366 |
| 118 | membrane budding (GO:0006900) | 2.45221886 |
| 119 | fatty acid beta-oxidation (GO:0006635) | 2.44916024 |
| 120 | negative regulation of protein ubiquitination (GO:0031397) | 2.44451994 |
| 121 | carnitine transmembrane transport (GO:1902603) | 2.44081470 |
| 122 | regulation of metalloenzyme activity (GO:0048552) | 2.43883045 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 2.43100345 |
| 124 | peptidyl-histidine modification (GO:0018202) | 2.42692401 |
| 125 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.42261216 |
| 126 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 2.41956526 |
| 127 | NADPH regeneration (GO:0006740) | 2.41712968 |
| 128 | vesicle coating (GO:0006901) | 2.41258478 |
| 129 | peroxisome fission (GO:0016559) | 2.41009169 |
| 130 | chaperone-mediated protein transport (GO:0072321) | 2.40792307 |
| 131 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.40582924 |
| 132 | protein carboxylation (GO:0018214) | 2.40532794 |
| 133 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.40532794 |
| 134 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.40375675 |
| 135 | cellular ketone body metabolic process (GO:0046950) | 2.40227517 |
| 136 | heme metabolic process (GO:0042168) | 2.39584694 |
| 137 | positive regulation of cell cycle arrest (GO:0071158) | 2.39331993 |
| 138 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.37270695 |
| 139 | hemoglobin metabolic process (GO:0020027) | 2.37064306 |
| 140 | heme biosynthetic process (GO:0006783) | 2.37061111 |
| 141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36457254 |
| 142 | leukocyte aggregation (GO:0070486) | 2.36166217 |
| 143 | glycolipid catabolic process (GO:0019377) | 2.36098872 |
| 144 | quinone biosynthetic process (GO:1901663) | 2.35988961 |
| 145 | necroptotic process (GO:0070266) | 2.35118631 |
| 146 | ribosomal large subunit biogenesis (GO:0042273) | 2.35000934 |
| 147 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.34967335 |
| 148 | positive regulation of receptor internalization (GO:0002092) | 2.34728381 |
| 149 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.34627508 |
| 150 | pentose-phosphate shunt (GO:0006098) | 2.33465577 |
| 151 | anterograde synaptic vesicle transport (GO:0048490) | 2.31333278 |
| 152 | vesicle fusion (GO:0006906) | 2.31310258 |
| 153 | glycerol ether metabolic process (GO:0006662) | 2.30894105 |
| 154 | response to type I interferon (GO:0034340) | 2.30713866 |
| 155 | lipid particle organization (GO:0034389) | 2.30258751 |
| 156 | regulation of natural killer cell differentiation (GO:0032823) | 2.28917908 |
| 157 | T cell migration (GO:0072678) | 2.28830925 |
| 158 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.28763793 |
| 159 | branched-chain amino acid metabolic process (GO:0009081) | 2.27875272 |
| 160 | cellular response to type I interferon (GO:0071357) | 2.27067423 |
| 161 | type I interferon signaling pathway (GO:0060337) | 2.27067423 |
| 162 | cellular response to exogenous dsRNA (GO:0071360) | 2.26103822 |
| 163 | striated muscle atrophy (GO:0014891) | 2.25816222 |
| 164 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25080864 |
| 165 | fatty acid oxidation (GO:0019395) | 2.24282759 |
| 166 | lipid oxidation (GO:0034440) | 2.23907892 |
| 167 | peptide catabolic process (GO:0043171) | 2.23873583 |
| 168 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.23544786 |
| 169 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.23489621 |
| 170 | tricarboxylic acid metabolic process (GO:0072350) | 2.23170181 |
| 171 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.23094485 |
| 172 | glyoxylate metabolic process (GO:0046487) | 2.22684192 |
| 173 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.19843387 |
| 174 | negative regulation of lipid storage (GO:0010888) | 2.18962465 |
| 175 | skeletal muscle adaptation (GO:0043501) | 2.18626016 |
| 176 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.17349129 |
| 177 | immunoglobulin mediated immune response (GO:0016064) | 2.17273262 |
| 178 | NADP metabolic process (GO:0006739) | 2.17104721 |
| 179 | hydrogen peroxide catabolic process (GO:0042744) | 2.15694072 |
| 180 | positive regulation of hemostasis (GO:1900048) | 2.13687578 |
| 181 | positive regulation of blood coagulation (GO:0030194) | 2.13687578 |
| 182 | short-chain fatty acid metabolic process (GO:0046459) | 2.13530552 |
| 183 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12306350 |
| 184 | modulation by symbiont of host defense response (GO:0052031) | 2.12306350 |
| 185 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12306350 |
| 186 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12306350 |
| 187 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12306350 |
| 188 | modulation by symbiont of host immune response (GO:0052553) | 2.12306350 |
| 189 | 2-oxoglutarate metabolic process (GO:0006103) | 2.11587763 |
| 190 | drug transmembrane transport (GO:0006855) | 2.11160961 |
| 191 | response to peptidoglycan (GO:0032494) | 2.10541506 |
| 192 | positive regulation of coagulation (GO:0050820) | 2.09891153 |
| 193 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.09595918 |
| 194 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.09440278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.13678721 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.54207621 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.91368719 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.84165603 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.78612915 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76211774 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.59526717 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.35042573 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11855265 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.03651235 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.98312912 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.94327351 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88815815 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88522585 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85149813 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.78676969 |
| 17 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.77147216 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72045237 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.68543116 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58850378 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.54313297 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45963465 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41789121 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40429084 |
| 25 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.36582257 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.31162618 |
| 27 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28427004 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26779539 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25847089 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21557734 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20014025 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17402158 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16312744 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11665655 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09912683 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07032508 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03510636 |
| 38 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.00668590 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98977981 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98142791 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96816235 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96728021 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93375828 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81919076 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.81895009 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80119287 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.79667918 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79325656 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63011357 |
| 50 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62285417 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61053156 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60383411 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57995082 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56777415 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54124914 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54070859 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.54006283 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.53922522 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52895095 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46673777 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46340357 |
| 62 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44883057 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44858728 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44715206 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43699603 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39696338 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35505224 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35395230 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34425070 |
| 70 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34175343 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34075109 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33327499 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32094893 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29594986 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.29483850 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29424585 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29323546 |
| 78 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26610125 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26128775 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24857938 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24144191 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24097615 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23680485 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23469687 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22914504 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22141163 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.21874457 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21593183 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20747096 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20622133 |
| 91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19831778 |
| 92 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.17205514 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17189417 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17001123 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16907035 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16311691 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16291684 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16189284 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13058974 |
| 100 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.12508133 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11698048 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08917767 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07811975 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07285046 |
| 105 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.06916742 |
| 106 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06495603 |
| 107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06459099 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05353833 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05262268 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04089344 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03104900 |
| 112 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.03024060 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02787057 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02109441 |
| 115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01748321 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01208806 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00994422 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00776434 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00484279 |
| 120 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00424505 |
| 121 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00346956 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99967026 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99348670 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98649700 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98425600 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98301208 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98059308 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98045960 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97256570 |
| 130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97199633 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96046052 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95565446 |
| 133 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95130987 |
| 134 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94908757 |
| 135 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.94648276 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93387833 |
| 137 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93330207 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91329121 |
| 139 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91273270 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90979332 |
| 141 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90095237 |
| 142 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89475316 |
| 143 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89380497 |
| 144 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89380497 |
| 145 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89297711 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89241554 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88773117 |
| 148 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88630292 |
| 149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88188048 |
| 150 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87759188 |
| 151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87420138 |
| 152 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87273532 |
| 153 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.85966538 |
| 154 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85556385 |
| 155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84604319 |
| 156 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84449787 |
| 157 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82953488 |
| 158 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.81385610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009697_abnormal_copulation | 4.08044534 |
| 2 | MP0003950_abnormal_plasma_membrane | 2.86352982 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.77219638 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.77050813 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 2.65861626 |
| 6 | MP0000685_abnormal_immune_system | 2.52568291 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.47673249 |
| 8 | MP0005360_urolithiasis | 2.41449154 |
| 9 | MP0009785_altered_susceptibility_to | 2.34167933 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.33410574 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.32819555 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.30631048 |
| 13 | MP0003436_decreased_susceptibility_to | 2.23654756 |
| 14 | MP0003724_increased_susceptibility_to | 2.21180401 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.19094611 |
| 16 | MP0003195_calcinosis | 2.12814322 |
| 17 | MP0006082_CNS_inflammation | 2.02319738 |
| 18 | MP0000372_irregular_coat_pigmentation | 1.99900496 |
| 19 | MP0006054_spinal_hemorrhage | 1.98772441 |
| 20 | MP0000013_abnormal_adipose_tissue | 1.98192197 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.93469911 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.92559372 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.91280042 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.88358062 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84693389 |
| 26 | MP0001727_abnormal_embryo_implantation | 1.83551591 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.83327808 |
| 28 | MP0003186_abnormal_redox_activity | 1.83209747 |
| 29 | MP0003786_premature_aging | 1.82958812 |
| 30 | MP0002419_abnormal_innate_immunity | 1.82400932 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.82237522 |
| 32 | MP0005025_abnormal_response_to | 1.81543777 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.80443709 |
| 34 | MP0005387_immune_system_phenotype | 1.79252741 |
| 35 | MP0001790_abnormal_immune_system | 1.79252741 |
| 36 | MP0003011_delayed_dark_adaptation | 1.76612775 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.70237411 |
| 38 | MP0005330_cardiomyopathy | 1.69989117 |
| 39 | MP0004147_increased_porphyrin_level | 1.68761061 |
| 40 | MP0000749_muscle_degeneration | 1.67735536 |
| 41 | MP0005365_abnormal_bile_salt | 1.67419569 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.65921620 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.62118881 |
| 44 | MP0002006_tumorigenesis | 1.60705826 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.58532582 |
| 46 | MP0001800_abnormal_humoral_immune | 1.55800426 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.55455722 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.55349620 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.55194551 |
| 50 | MP0001853_heart_inflammation | 1.55030431 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.53543717 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.52528317 |
| 53 | MP0001958_emphysema | 1.52318699 |
| 54 | MP0005671_abnormal_response_to | 1.50989439 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.50868531 |
| 56 | MP0005083_abnormal_biliary_tract | 1.49537980 |
| 57 | MP0009764_decreased_sensitivity_to | 1.47830725 |
| 58 | MP0000358_abnormal_cell_content/ | 1.47400147 |
| 59 | MP0008058_abnormal_DNA_repair | 1.45862181 |
| 60 | MP0005332_abnormal_amino_acid | 1.45717192 |
| 61 | MP0003252_abnormal_bile_duct | 1.45143332 |
| 62 | MP0002723_abnormal_immune_serum | 1.44026601 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.41920639 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.40100751 |
| 65 | MP0008469_abnormal_protein_level | 1.39694368 |
| 66 | MP0009840_abnormal_foam_cell | 1.39386116 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.38324192 |
| 68 | MP0004947_skin_inflammation | 1.37884667 |
| 69 | MP0008775_abnormal_heart_ventricle | 1.36232684 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33551834 |
| 71 | MP0002420_abnormal_adaptive_immunity | 1.33354982 |
| 72 | MP0001819_abnormal_immune_cell | 1.33114688 |
| 73 | MP0005165_increased_susceptibility_to | 1.33112212 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.33002520 |
| 75 | MP0002405_respiratory_system_inflammati | 1.25148896 |
| 76 | MP0000609_abnormal_liver_physiology | 1.24296529 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.23281172 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.21948864 |
| 79 | MP0003828_pulmonary_edema | 1.21130467 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.20346290 |
| 81 | MP0009763_increased_sensitivity_to | 1.20131263 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 1.20047883 |
| 83 | MP0000747_muscle_weakness | 1.18529618 |
| 84 | MP0003718_maternal_effect | 1.17721576 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 1.16786738 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14096089 |
| 87 | MP0002933_joint_inflammation | 1.13942853 |
| 88 | MP0001873_stomach_inflammation | 1.13710837 |
| 89 | MP0004957_abnormal_blastocyst_morpholog | 1.11133525 |
| 90 | MP0001666_abnormal_nutrient_absorption | 1.10430979 |
| 91 | MP0010155_abnormal_intestine_physiology | 1.09188121 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.08219533 |
| 93 | MP0010329_abnormal_lipoprotein_level | 1.08128797 |
| 94 | MP0005451_abnormal_body_composition | 1.07727054 |
| 95 | MP0001764_abnormal_homeostasis | 1.07084355 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 1.07050541 |
| 97 | MP0003763_abnormal_thymus_physiology | 1.05709749 |
| 98 | MP0002136_abnormal_kidney_physiology | 1.05125331 |
| 99 | MP0000858_altered_metastatic_potential | 1.04899568 |
| 100 | MP0000716_abnormal_immune_system | 1.04092485 |
| 101 | MP0000343_altered_response_to | 1.03053706 |
| 102 | MP0002398_abnormal_bone_marrow | 1.02056243 |
| 103 | MP0004484_altered_response_of | 1.02025584 |
| 104 | MP0002876_abnormal_thyroid_physiology | 1.00717987 |
| 105 | MP0003566_abnormal_cell_adhesion | 1.00034952 |
| 106 | MP0005408_hypopigmentation | 0.99995465 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.99334643 |
| 108 | MP0001661_extended_life_span | 0.97910158 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.97629602 |
| 110 | MP0002269_muscular_atrophy | 0.97398506 |
| 111 | MP0003303_peritoneal_inflammation | 0.97214013 |
| 112 | MP0002254_reproductive_system_inflammat | 0.94428446 |
| 113 | MP0003279_aneurysm | 0.94345044 |
| 114 | MP0002127_abnormal_cardiovascular_syste | 0.94106141 |
| 115 | MP0002971_abnormal_brown_adipose | 0.92272180 |
| 116 | MP0002429_abnormal_blood_cell | 0.92253248 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.91782372 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.91741651 |
| 119 | MP0000598_abnormal_liver_morphology | 0.91377919 |
| 120 | MP0008260_abnormal_autophagy | 0.91253482 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.90147315 |
| 122 | MP0000604_amyloidosis | 0.89861107 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.89539165 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.86706400 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.86672007 |
| 126 | MP0003448_altered_tumor_morphology | 0.86634061 |
| 127 | MP0003868_abnormal_feces_composition | 0.85028064 |
| 128 | MP0005266_abnormal_metabolism | 0.84843267 |
| 129 | MP0000249_abnormal_blood_vessel | 0.84510999 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.84297365 |
| 131 | MP0004043_abnormal_pH_regulation | 0.83254077 |
| 132 | MP0005395_other_phenotype | 0.83039645 |
| 133 | MP0002722_abnormal_immune_system | 0.82340763 |
| 134 | MP0002168_other_aberrant_phenotype | 0.81858396 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.81392867 |
| 136 | MP0001756_abnormal_urination | 0.80032802 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.79191549 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.79182378 |
| 139 | MP0003646_muscle_fatigue | 0.78209436 |
| 140 | MP0005410_abnormal_fertilization | 0.78071597 |
| 141 | MP0004130_abnormal_muscle_cell | 0.76608011 |
| 142 | MP0004510_myositis | 0.75913882 |
| 143 | MP0010368_abnormal_lymphatic_system | 0.75562378 |
| 144 | MP0003795_abnormal_bone_structure | 0.74467732 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.74319001 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.74319001 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.73587744 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.72479572 |
| 149 | MP0005220_abnormal_exocrine_pancreas | 0.71890590 |
| 150 | MP0004233_abnormal_muscle_weight | 0.71415785 |
| 151 | MP0005376_homeostasis/metabolism_phenot | 0.71373017 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.71256801 |
| 153 | MP0004272_abnormal_basement_membrane | 0.70114405 |
| 154 | MP0005164_abnormal_response_to | 0.69460746 |
| 155 | MP0004087_abnormal_muscle_fiber | 0.68397973 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.66807716 |
| 157 | MP0001730_embryonic_growth_arrest | 0.66005877 |
| 158 | MP0009115_abnormal_fat_cell | 0.59597390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 4.20670283 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.20378050 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.95397845 |
| 4 | Fatigue (HP:0012378) | 3.78380782 |
| 5 | Progressive external ophthalmoplegia (HP:0000590) | 3.76555266 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.62719951 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.43061830 |
| 8 | Sensory axonal neuropathy (HP:0003390) | 3.41922840 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.36378625 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.23056429 |
| 11 | Hepatic necrosis (HP:0002605) | 3.19858185 |
| 12 | Nemaline bodies (HP:0003798) | 3.17534112 |
| 13 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.14981709 |
| 14 | Progressive muscle weakness (HP:0003323) | 3.14767224 |
| 15 | Generalized aminoaciduria (HP:0002909) | 3.08917970 |
| 16 | Abnormality of macrophages (HP:0004311) | 2.96529637 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.94680352 |
| 18 | Hypokinesia (HP:0002375) | 2.94516581 |
| 19 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.94511759 |
| 20 | Hypoglycemic coma (HP:0001325) | 2.94104894 |
| 21 | Vascular calcification (HP:0004934) | 2.93079251 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 2.92709973 |
| 23 | Muscle fiber inclusion bodies (HP:0100299) | 2.91701129 |
| 24 | Xanthomatosis (HP:0000991) | 2.82950387 |
| 25 | Cardiovascular calcification (HP:0011915) | 2.82553401 |
| 26 | Autoimmune hemolytic anemia (HP:0001890) | 2.78006511 |
| 27 | Metaphyseal dysplasia (HP:0100255) | 2.68937878 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.67754449 |
| 29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.67625652 |
| 30 | Increased serum pyruvate (HP:0003542) | 2.65921610 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65400147 |
| 32 | Myocardial infarction (HP:0001658) | 2.64011875 |
| 33 | Amniotic constriction ring (HP:0009775) | 2.62765549 |
| 34 | Abnormality of placental membranes (HP:0011409) | 2.62765549 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62282038 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 2.61487385 |
| 37 | Paralysis (HP:0003470) | 2.60458123 |
| 38 | Deep venous thrombosis (HP:0002625) | 2.55413425 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53714879 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53714879 |
| 41 | Increased muscle lipid content (HP:0009058) | 2.53590393 |
| 42 | Nausea (HP:0002018) | 2.53217544 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.53118056 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53118056 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.52253047 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.51637026 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.51494832 |
| 48 | Recurrent viral infections (HP:0004429) | 2.50668001 |
| 49 | Rhabdomyolysis (HP:0003201) | 2.49490489 |
| 50 | Recurrent skin infections (HP:0001581) | 2.48534012 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.48382866 |
| 52 | Exercise intolerance (HP:0003546) | 2.46549059 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45230048 |
| 54 | Hepatocellular necrosis (HP:0001404) | 2.44408916 |
| 55 | Increased CSF lactate (HP:0002490) | 2.43744935 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.43235856 |
| 57 | Complement deficiency (HP:0004431) | 2.42575035 |
| 58 | Ketosis (HP:0001946) | 2.41125902 |
| 59 | Steatorrhea (HP:0002570) | 2.40026752 |
| 60 | Cholelithiasis (HP:0001081) | 2.38350639 |
| 61 | Abnormality of glycolysis (HP:0004366) | 2.36479558 |
| 62 | Aortic aneurysm (HP:0004942) | 2.34568537 |
| 63 | Poikilocytosis (HP:0004447) | 2.34296538 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.34092881 |
| 65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33795249 |
| 66 | Osteolytic defects of the hand bones (HP:0009699) | 2.33795249 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33445140 |
| 68 | Tetraparesis (HP:0002273) | 2.32851468 |
| 69 | Abnormal hemoglobin (HP:0011902) | 2.31432192 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30052075 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30052075 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30052075 |
| 73 | Premature ovarian failure (HP:0008209) | 2.29952131 |
| 74 | Chronic otitis media (HP:0000389) | 2.29804172 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.29530911 |
| 76 | Urticaria (HP:0001025) | 2.29453320 |
| 77 | Progressive macrocephaly (HP:0004481) | 2.25901970 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24808661 |
| 79 | Gingivitis (HP:0000230) | 2.24179867 |
| 80 | Recurrent fungal infections (HP:0002841) | 2.23283555 |
| 81 | Polycythemia (HP:0001901) | 2.21806976 |
| 82 | Cerebral hemorrhage (HP:0001342) | 2.19568927 |
| 83 | Palpitations (HP:0001962) | 2.19400785 |
| 84 | Acute encephalopathy (HP:0006846) | 2.18439271 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.15384959 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.13745246 |
| 87 | Hyperammonemia (HP:0001987) | 2.10895840 |
| 88 | Cerebral edema (HP:0002181) | 2.10260008 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.09786332 |
| 90 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09139981 |
| 91 | Myoglobinuria (HP:0002913) | 2.09078155 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.06591044 |
| 93 | Purpura (HP:0000979) | 2.06567150 |
| 94 | Joint hemorrhage (HP:0005261) | 2.06538721 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 2.06526137 |
| 96 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06483443 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.05362387 |
| 98 | Intrahepatic cholestasis (HP:0001406) | 2.04276204 |
| 99 | Increased serum lactate (HP:0002151) | 2.04262286 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.04223469 |
| 101 | Fat malabsorption (HP:0002630) | 2.03806106 |
| 102 | Renal Fanconi syndrome (HP:0001994) | 2.02590626 |
| 103 | Petechiae (HP:0000967) | 2.01753852 |
| 104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01700913 |
| 105 | Ketoacidosis (HP:0001993) | 2.01378054 |
| 106 | Impaired proprioception (HP:0010831) | 1.99700819 |
| 107 | Popliteal pterygium (HP:0009756) | 1.98877345 |
| 108 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98713411 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 1.98640221 |
| 110 | Lactic acidosis (HP:0003128) | 1.98604895 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.98190368 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.98190368 |
| 113 | Cellulitis (HP:0100658) | 1.97372966 |
| 114 | Lipid accumulation in hepatocytes (HP:0006561) | 1.97168748 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 1.96205280 |
| 116 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95570474 |
| 117 | Abnormality of lateral ventricle (HP:0030047) | 1.95469571 |
| 118 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94838143 |
| 119 | Renal cortical cysts (HP:0000803) | 1.94426761 |
| 120 | Prolonged partial thromboplastin time (HP:0003645) | 1.94375403 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94045019 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.94045019 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.92579534 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91964527 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.91867608 |
| 126 | Hyperphosphatemia (HP:0002905) | 1.91699166 |
| 127 | Orthostatic hypotension (HP:0001278) | 1.91687622 |
| 128 | Abnormality of glycine metabolism (HP:0010895) | 1.91538150 |
| 129 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.91538150 |
| 130 | Hypertriglyceridemia (HP:0002155) | 1.90840027 |
| 131 | Abnormality of complement system (HP:0005339) | 1.89300721 |
| 132 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89212902 |
| 133 | Esophageal varix (HP:0002040) | 1.89196917 |
| 134 | Myositis (HP:0100614) | 1.87880095 |
| 135 | Hyperlipoproteinemia (HP:0010980) | 1.87008635 |
| 136 | Acanthocytosis (HP:0001927) | 1.86714272 |
| 137 | Beaking of vertebral bodies (HP:0004568) | 1.86611027 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.86562247 |
| 139 | Cholecystitis (HP:0001082) | 1.86407331 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.86407331 |
| 141 | Osteomyelitis (HP:0002754) | 1.86176351 |
| 142 | Lethargy (HP:0001254) | 1.86124014 |
| 143 | Hyperglycinemia (HP:0002154) | 1.85464970 |
| 144 | Glycosuria (HP:0003076) | 1.85058871 |
| 145 | Abnormality of urine glucose concentration (HP:0011016) | 1.85058871 |
| 146 | Ileus (HP:0002595) | 1.84978146 |
| 147 | Hyperbilirubinemia (HP:0002904) | 1.84557358 |
| 148 | Neuroendocrine neoplasm (HP:0100634) | 1.84492758 |
| 149 | Methylmalonic acidemia (HP:0002912) | 1.83154803 |
| 150 | Spondylolisthesis (HP:0003302) | 1.82750179 |
| 151 | Abnormality of alanine metabolism (HP:0010916) | 1.82388405 |
| 152 | Hyperalaninemia (HP:0003348) | 1.82388405 |
| 153 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82388405 |
| 154 | Recurrent bronchitis (HP:0002837) | 1.81714784 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.81101886 |
| 156 | Hepatocellular carcinoma (HP:0001402) | 1.80742404 |
| 157 | Bundle branch block (HP:0011710) | 1.80443710 |
| 158 | Exercise-induced muscle cramps (HP:0003710) | 1.80226194 |
| 159 | Increased purine levels (HP:0004368) | 1.80206691 |
| 160 | Hyperuricemia (HP:0002149) | 1.80206691 |
| 161 | CNS demyelination (HP:0007305) | 1.78990009 |
| 162 | Metabolic acidosis (HP:0001942) | 1.78766730 |
| 163 | T lymphocytopenia (HP:0005403) | 1.78187744 |
| 164 | Hemorrhage of the eye (HP:0011885) | 1.77078512 |
| 165 | Axonal loss (HP:0003447) | 1.75811423 |
| 166 | Progressive hearing impairment (HP:0001730) | 1.75371329 |
| 167 | Abnormality of T cell physiology (HP:0011840) | 1.75355982 |
| 168 | Peritonitis (HP:0002586) | 1.74302066 |
| 169 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73696286 |
| 170 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73696286 |
| 171 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73696286 |
| 172 | Vasculitis (HP:0002633) | 1.72828506 |
| 173 | Respiratory failure (HP:0002878) | 1.72589404 |
| 174 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.72058854 |
| 175 | Calf muscle hypertrophy (HP:0008981) | 1.71429417 |
| 176 | Abnormality of the gallbladder (HP:0005264) | 1.71423377 |
| 177 | Type I transferrin isoform profile (HP:0003642) | 1.71080999 |
| 178 | Pathologic fracture (HP:0002756) | 1.71010291 |
| 179 | Distal arthrogryposis (HP:0005684) | 1.70634913 |
| 180 | Abnormal protein glycosylation (HP:0012346) | 1.69507001 |
| 181 | Abnormal glycosylation (HP:0012345) | 1.69507001 |
| 182 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.69507001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 3.43876740 |
| 2 | MAP3K12 | 3.14214762 |
| 3 | NEK1 | 2.92007890 |
| 4 | MAP3K14 | 2.70531088 |
| 5 | MAP4K1 | 2.28270247 |
| 6 | TBK1 | 2.28017564 |
| 7 | ERN1 | 2.20508170 |
| 8 | TYK2 | 2.17459228 |
| 9 | IRAK4 | 2.15319947 |
| 10 | NEK9 | 2.10014007 |
| 11 | PDK2 | 2.04658811 |
| 12 | BCKDK | 2.01637340 |
| 13 | IRAK3 | 1.99893938 |
| 14 | MAP3K3 | 1.99840766 |
| 15 | TXK | 1.99046045 |
| 16 | MST4 | 1.98286862 |
| 17 | STK10 | 1.97444179 |
| 18 | PBK | 1.97270954 |
| 19 | TIE1 | 1.97135949 |
| 20 | JAK3 | 1.95170868 |
| 21 | FLT3 | 1.84401767 |
| 22 | LMTK2 | 1.84304843 |
| 23 | MAP3K2 | 1.84064619 |
| 24 | PIK3CG | 1.72798571 |
| 25 | TTN | 1.72618062 |
| 26 | JAK1 | 1.72457503 |
| 27 | FGFR4 | 1.71306026 |
| 28 | EPHB1 | 1.71184995 |
| 29 | LRRK2 | 1.71073059 |
| 30 | TAOK3 | 1.68117326 |
| 31 | IKBKE | 1.66337083 |
| 32 | TEC | 1.63815736 |
| 33 | TRIM28 | 1.59635091 |
| 34 | TRPM7 | 1.56608435 |
| 35 | ZAP70 | 1.55208187 |
| 36 | KIT | 1.48298499 |
| 37 | CAMK1D | 1.48073754 |
| 38 | MAPKAPK3 | 1.40108477 |
| 39 | EPHA3 | 1.37224206 |
| 40 | FRK | 1.36783011 |
| 41 | TRIB3 | 1.35670453 |
| 42 | PTK6 | 1.35606802 |
| 43 | CSK | 1.35076506 |
| 44 | NME2 | 1.32460867 |
| 45 | KDR | 1.31783918 |
| 46 | BLK | 1.28216264 |
| 47 | ITK | 1.26173003 |
| 48 | MAP4K2 | 1.24977505 |
| 49 | BTK | 1.22810337 |
| 50 | IKBKB | 1.20348770 |
| 51 | SIK1 | 1.18622187 |
| 52 | PIK3CA | 1.16809120 |
| 53 | RPS6KA4 | 1.15116990 |
| 54 | RAF1 | 1.14035282 |
| 55 | SYK | 1.12301099 |
| 56 | WNK4 | 1.12098385 |
| 57 | CCNB1 | 1.09511957 |
| 58 | ERBB3 | 1.09404867 |
| 59 | NUAK1 | 1.08903666 |
| 60 | EPHA2 | 1.03464289 |
| 61 | PKN2 | 1.03214421 |
| 62 | KSR2 | 1.01792957 |
| 63 | TESK1 | 1.01409205 |
| 64 | CSF1R | 0.97581093 |
| 65 | MYLK | 0.97312410 |
| 66 | PRKCQ | 0.95782001 |
| 67 | JAK2 | 0.94455222 |
| 68 | MAPKAPK5 | 0.93905007 |
| 69 | TGFBR2 | 0.92925515 |
| 70 | ARAF | 0.92147498 |
| 71 | LCK | 0.90870587 |
| 72 | MELK | 0.90468960 |
| 73 | STK4 | 0.88846532 |
| 74 | PAK4 | 0.88782044 |
| 75 | RPS6KB2 | 0.88245064 |
| 76 | OBSCN | 0.86637554 |
| 77 | AKT2 | 0.84689064 |
| 78 | STK16 | 0.84536172 |
| 79 | MAP2K1 | 0.84293017 |
| 80 | PHKG1 | 0.83458722 |
| 81 | PHKG2 | 0.83458722 |
| 82 | EIF2AK1 | 0.83292521 |
| 83 | ABL2 | 0.81795459 |
| 84 | MST1R | 0.81736896 |
| 85 | MAP2K3 | 0.79257067 |
| 86 | LYN | 0.79027683 |
| 87 | CHUK | 0.78228292 |
| 88 | IRAK1 | 0.78158761 |
| 89 | TSSK6 | 0.75705269 |
| 90 | ILK | 0.75498029 |
| 91 | LIMK1 | 0.74526251 |
| 92 | HCK | 0.74373894 |
| 93 | PIM1 | 0.73991695 |
| 94 | TTK | 0.71689872 |
| 95 | PRKG2 | 0.71656081 |
| 96 | MARK3 | 0.71439663 |
| 97 | BMX | 0.69568824 |
| 98 | TLK1 | 0.69065854 |
| 99 | FER | 0.68636362 |
| 100 | DYRK3 | 0.67244152 |
| 101 | SCYL2 | 0.67079437 |
| 102 | FGFR3 | 0.66372928 |
| 103 | STK24 | 0.65736634 |
| 104 | RIPK1 | 0.64631961 |
| 105 | MAP3K13 | 0.62995682 |
| 106 | MAPK11 | 0.62379089 |
| 107 | MAP3K8 | 0.61426613 |
| 108 | MET | 0.60549923 |
| 109 | TESK2 | 0.58215027 |
| 110 | ACVR1B | 0.57803536 |
| 111 | MAP3K5 | 0.57534134 |
| 112 | PLK1 | 0.57262284 |
| 113 | PRKD2 | 0.57262014 |
| 114 | MAPKAPK2 | 0.56899711 |
| 115 | STK3 | 0.55895342 |
| 116 | GRK7 | 0.55426319 |
| 117 | PLK3 | 0.53941125 |
| 118 | BRSK2 | 0.52656414 |
| 119 | PRKCD | 0.50383042 |
| 120 | PRKD1 | 0.48766871 |
| 121 | BMPR2 | 0.48546662 |
| 122 | STK39 | 0.48366553 |
| 123 | IGF1R | 0.48311335 |
| 124 | EGFR | 0.47959235 |
| 125 | CAMKK2 | 0.46155075 |
| 126 | BUB1 | 0.46136323 |
| 127 | PAK3 | 0.42990098 |
| 128 | PRKCH | 0.42893326 |
| 129 | PDK1 | 0.42535448 |
| 130 | MAP3K1 | 0.42209201 |
| 131 | PRKAA2 | 0.41715677 |
| 132 | RIPK4 | 0.41484413 |
| 133 | KSR1 | 0.40168661 |
| 134 | PDPK1 | 0.40102572 |
| 135 | DYRK1B | 0.40048618 |
| 136 | CSNK1A1L | 0.39756574 |
| 137 | STK38 | 0.39701563 |
| 138 | INSR | 0.39655259 |
| 139 | PTK2B | 0.39520562 |
| 140 | FES | 0.39139445 |
| 141 | PIM2 | 0.38196400 |
| 142 | CAMK1G | 0.37132355 |
| 143 | ZAK | 0.36683845 |
| 144 | CSNK1G3 | 0.36605878 |
| 145 | ABL1 | 0.36511995 |
| 146 | INSRR | 0.36315485 |
| 147 | BRAF | 0.34083514 |
| 148 | SRPK1 | 0.33240469 |
| 149 | PRKACB | 0.32662995 |
| 150 | TAOK2 | 0.31508896 |
| 151 | PAK1 | 0.30996758 |
| 152 | CLK1 | 0.30203093 |
| 153 | DAPK3 | 0.27937504 |
| 154 | PRKCI | 0.27770425 |
| 155 | PLK2 | 0.27396809 |
| 156 | CSNK2A1 | 0.26882486 |
| 157 | DAPK1 | 0.26873392 |
| 158 | TAOK1 | 0.25398926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.72239708 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.83117401 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.48754731 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.21960693 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.21280038 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.08957768 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07567749 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 2.06323180 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.95025054 |
| 10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.94389956 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92048839 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90861092 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88078879 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.78318444 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78288758 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75973644 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.74144540 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68844921 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67125829 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.65790459 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64939636 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.54050933 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53858975 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53794204 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.51900150 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50413495 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.49986600 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48491304 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.45131792 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43560470 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42190172 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.40715185 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40342783 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38145351 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38138789 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.37736341 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36905922 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34970350 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.34878493 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34627359 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34206449 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26751393 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23339148 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17964067 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.17862328 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17025902 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16247149 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16115037 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14463453 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12201565 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11828111 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09267837 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08928331 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.08419516 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08153450 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08117715 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05084447 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04554677 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04364184 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 1.04061269 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01355341 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.99984802 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99975190 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97787241 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96216611 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.95801520 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94576679 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.94441851 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94412994 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93039868 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92108987 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90847736 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90647660 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89911322 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89502039 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84826628 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.84093482 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83871767 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83075660 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82800369 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81486531 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80381735 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80199304 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80093593 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79615557 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79269840 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78985084 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78266700 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78177829 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77868316 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75470453 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75199433 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74864873 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.74602806 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73831732 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.73738069 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72035560 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.70612573 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.70552267 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69292833 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66642776 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66075527 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65274611 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64648861 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64620020 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64614502 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62283435 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62129886 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61773067 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60976754 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.58139866 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58065402 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56342227 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55584925 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.55421313 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54687691 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54644195 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54159119 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53535071 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.53442626 |
| 121 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53311208 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52986665 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51316140 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.50999975 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50968648 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50474689 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49846016 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.47931152 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47798174 |
| 130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47363751 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46247659 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45992033 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45170802 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43884362 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.43870671 |
| 136 | Asthma_Homo sapiens_hsa05310 | 0.43175627 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42533915 |
| 138 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42466007 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42177955 |
| 140 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38259151 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.37283763 |
| 142 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.35095351 |
| 143 | RNA transport_Homo sapiens_hsa03013 | 0.35088300 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.34387322 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33083867 |
| 146 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31044034 |

